Market Outlook

By 2035, the U.S. Minimally Invasive Gastroenterology Devices Market is projected to reach approximately USD 16.44 billion, expanding at a CAGR of 8.05% during the forecast period 2026–2035. The market is estimated at USD 7.58 billion in 2025, with historical analysis covering 2021–2024. Values in this report are expressed in USD billions.

For market-sizing purposes, minimally invasive gastroenterology devices include technologies used by gastroenterologists and advanced endoscopists to visualize, diagnose, access, resect, ablate, dilate, drain, close, stent, biopsy, suture, decompress, and otherwise treat gastrointestinal and pancreatobiliary disease through endoscopic or endoluminal approaches. The scope includes gastrointestinal endoscopes and visualization platforms, endotherapy accessories, endoscopic ultrasound devices, ERCP and cholangioscopy products, gastrointestinal stents, dilation systems, tissue-acquisition devices, capsule endoscopy, single-use endoscopes, endoscopic suturing and closure technologies, hemostasis devices, and selected bariatric and metabolic endoscopy technologies. General laparoscopic surgical instruments primarily purchased for conventional gastrointestinal surgery are excluded to prevent category inflation.

The U.S. market sits at the intersection of three high-value healthcare priorities: earlier gastrointestinal disease detection, migration from open or laparoscopic surgery toward endoluminal treatment, and movement of appropriate procedures into outpatient environments. Gastroenterology is becoming progressively more intervention-oriented. A modern GI laboratory no longer functions exclusively as a diagnostic environment; advanced centers can remove complex lesions, manage bleeding, drain pancreatic collections, treat biliary obstruction, close perforations or fistulas, perform endoscopic sleeve gastroplasty, access tissue through endoscopic ultrasound, and manage selected precancerous conditions without traditional surgery.

The addressable clinical population is substantial. Colorectal cancer remains one of the most important gastrointestinal malignancies in the country, with more than 155,000 new cases reported in 2023. Current U.S. screening recommendations generally cover adults aged 45–75, yet approximately one-third of eligible adults remained not up to date with colorectal cancer screening in 2023. Pancreatic cancer adds another clinically intensive population, with approximately 67,440 new U.S. cases estimated for 2025. Chronic gastrointestinal conditions also generate recurring procedural demand: around one million Americans are estimated to live with Crohn’s disease, while roughly 600,000–900,000 live with ulcerative colitis.

Historical market value increased from approximately USD 5.16 billion in 2021 to USD 6.94 billion in 2024. Recovery of elective colonoscopy and upper-GI procedure volumes after the pandemic was an important initial contributor, but growth increasingly shifted toward premium technologies such as endoscopic ultrasound, digital cholangioscopy, lumen-apposing metal stents, advanced tissue closure, image-enhanced endoscopy, AI-assisted polyp detection, single-use devices, and therapeutic endoluminal platforms.

The 2025 valuation of USD 7.58 billion reflects a category-reconciled market model rather than the reuse of a broader U.S. endoscopy market estimate. Through 2035, value growth is expected to outpace procedure growth because the product mix is migrating toward higher-value visualization, therapeutic consumables, software-assisted imaging, complex pancreaticobiliary interventions, tissue acquisition, endoscopic bariatric procedures, and devices that substitute for surgery or shorten inpatient utilization.

 

Introduction

According to the U.S. Minimally Invasive Gastroenterology Devices Market Report, the market is evolving from a traditional endoscopy equipment industry into an integrated procedural ecosystem encompassing diagnosis, intervention, workflow intelligence, infection prevention, tissue management, and outpatient care.

The economic importance of these technologies extends beyond the selling price of an endoscope, stent, clip, catheter, or processor. Hospitals increasingly assess gastroenterology devices through total procedural economics. Factors such as procedure duration, scope turnaround time, anesthesia utilization, reprocessing cost, pathology yield, repeat procedure rates, complication avoidance, recovery time, hospital admission prevention, physician productivity, and reimbursement determine whether a technology gains system-wide adoption.

This procurement logic favors minimally invasive technologies capable of replacing higher-cost episodes of care. Endoscopic mucosal resection and endoscopic submucosal dissection can reduce the need for surgical resection in appropriately selected lesions. EUS-guided drainage can replace more invasive approaches for selected pancreatic fluid collections. Endoscopic suturing and defect-closure systems allow gastroenterologists to manage increasingly complex tissue defects. Endoscopic bariatric technologies provide an intermediate therapeutic pathway between lifestyle or pharmacological management and bariatric surgery for selected patients.

The U.S. obesity burden is particularly relevant to the emerging endobariatric market. Approximately 40.3% of U.S. adults were living with obesity during August 2021–August 2023, while severe obesity affected a substantial additional population. In 2023, 23 states had an adult obesity prevalence of at least 35%. This creates a large potential population for multidisciplinary obesity management, although adoption of endoscopic weight-loss procedures will depend on patient selection, reimbursement, physician training, competition from GLP-1 therapies, and long-term outcomes.

The site of care is also changing. The U.S. had approximately 6,436 ambulatory surgical centers in 2024, and these facilities treated roughly 3.4 million fee-for-service Medicare beneficiaries. Gastrointestinal endoscopy is particularly suitable for outpatient migration because a large proportion of colonoscopy, upper-GI endoscopy, polypectomy, biopsy, dilation, and selected therapeutic procedures can be performed without inpatient admission.

From 2026 through 2035, competitive advantage will therefore depend less on isolated device performance and more on whether manufacturers can build a commercially coherent GI procedural platform. Leading vendors will be expected to support visualization, therapy, infection control, training, inventory management, reimbursement, clinical evidence, data capture, and increasingly AI-enabled workflow.

 

Key Market Drivers: What Is Expanding the U.S. Minimally Invasive Gastroenterology Devices Market?

The first structural driver is the scale of colorectal screening, surveillance, and therapeutic colonoscopy. Colorectal cancer is among the most preventable major malignancies because identification and removal of precancerous polyps can interrupt progression to cancer. The expansion of routine screening eligibility to adults beginning at age 45 enlarged the addressable population for colonoscopy and associated endoscopic devices. At the same time, incomplete screening adherence means the U.S. continues to have a substantial backlog of eligible adults who may enter screening pathways during the forecast period.

This creates recurring demand for colonoscopes, visualization systems, snares, biopsy forceps, injection needles, clips, retrieval devices, irrigation pumps, electrosurgical systems, AI-based detection modules, and pathology-oriented tissue acquisition technologies. Colonoscopy economics are particularly attractive to suppliers because procedures combine reusable capital equipment with substantial recurring disposable-device consumption.

The second driver is the shift from diagnostic endoscopy toward therapeutic endoscopy. Advanced endoscopists increasingly treat lesions that historically required surgery or interventional radiology. EMR, ESD, POEM, endoscopic full-thickness resection, suturing, endoscopic vacuum therapy, endoluminal defect closure, endoscopic ablation, and complex hemostasis broaden the amount of device revenue generated per advanced GI procedure.

For hospitals, the strategic advantage is the possibility of reducing surgical trauma, postoperative utilization, and length of stay. For manufacturers, the commercial advantage is the creation of premium disposable-device categories around established endoscopy platforms. This means procedure complexity, rather than only procedure count, will be a major contributor to market expansion.

The third driver is the rising burden of pancreatic and biliary disease. Pancreatic cancer remains among the most lethal U.S. cancers, with approximately 67,440 new cases and nearly 52,000 deaths estimated in 2025. Biliary obstruction, pancreatic masses, gallstone-related complications, strictures, pancreatitis, and pancreatic fluid collections create demand for EUS, ERCP, cholangioscopy, fine-needle biopsy, guidewires, sphincterotomes, extraction balloons, baskets, biliary and pancreatic stents, lithotripsy devices, and lumen-apposing metal stents.

Advanced pancreaticobiliary procedures are commercially important because they require multiple procedure-specific accessories. Hospitals also tend to centralize these cases in high-acuity centers, allowing manufacturers to build deep relationships with advanced endoscopists and purchasing committees.

The fourth driver is AI-enabled colonoscopy and image-enhanced endoscopy. Artificial intelligence is moving into mainstream gastroenterology as health systems seek to reduce variation in adenoma detection, document procedure quality, support less experienced clinicians, and create structured endoscopy data. Computer-aided detection does not replace the gastroenterologist; its near-term value proposition is assisting lesion recognition while reducing preventable misses.

This changes capital purchasing because image processors, endoscopy towers, AI modules, scopes, software, and data integration increasingly become part of a single technology decision. Vendors that create upgradeable platforms can increase customer retention and generate recurring software or service opportunities around the installed equipment base.

The fifth driver is outpatient migration. ASCs and physician-affiliated endoscopy centers are highly sensitive to room turnover, equipment uptime, staffing requirements, reprocessing efficiency, disposable cost, and reimbursement per case. Products designed for faster setup, standardized use, low training burden, fewer repeat procedures, and simplified inventory management have an advantage in these environments.

The approximately 6,400 Medicare-participating ASCs operating nationally demonstrate how substantial the outpatient infrastructure has become. The commercial implication for suppliers is that successful GI portfolios must now address two different purchasing environments: sophisticated tertiary hospitals seeking high-end therapeutic capability and high-throughput ambulatory centers seeking reliable procedure economics.

The sixth driver is infection prevention and reprocessing economics. Flexible endoscopes have complex internal channels that require validated cleaning and high-level disinfection or sterilization protocols. U.S. regulatory scrutiny of reusable endoscope reprocessing, particularly duodenoscopes, has encouraged design changes, disposable distal components, single-use scopes, and greater attention to traceability.

Single-use gastroenterology devices will not replace reusable endoscopy universally because procedure economics remain important. Their strongest opportunities are likely to occur in high-risk patients, urgent procedures, low-volume locations, procedural overflow, facilities without efficient reprocessing capacity, and device categories where cross-contamination risk is disproportionately important.

A seventh driver is chronic inflammatory gastrointestinal disease. Approximately one million Americans are estimated to have Crohn’s disease and between 600,000 and 900,000 ulcerative colitis. These conditions require recurring endoscopic assessment for disease activity, strictures, dysplasia, treatment response, and cancer surveillance. Unlike one-time diagnostic procedures, chronic disease management creates repeat utilization over many years.

An eighth driver is the U.S. specialist and hospital innovation ecosystem. Academic medical centers and high-volume GI programs act as technology diffusion hubs. Techniques such as ESD, POEM, advanced EUS, endoscopic suturing, third-space endoscopy, cholangioscopy, and endobariatric intervention typically gain adoption first in specialized centers before expanding into regional health systems. Manufacturers that establish strong training infrastructure can therefore accelerate the commercial diffusion of complex devices.

 

Innovation in Focus: How Manufacturers Are Raising the Bar

The strongest innovation theme is the transition from visualization to intelligent visualization. Conventional high-definition white-light endoscopy is increasingly augmented by narrow-band, linked-color, texture-enhancement, red-dichromatic, extended-depth-of-field, and AI-supported technologies. The objective is not merely sharper imaging; it is improved lesion recognition, mucosal characterization, bleeding visualization, and procedural confidence.

AI-assisted colonoscopy is becoming one of the most visible areas of competition. Systems are moving from first-generation polyp alerts toward platforms capable of supporting detection, characterization, automated documentation, quality measurement, and third-party applications. Over time, this could shift purchasing behavior from standalone endoscopy processors toward software-upgradeable GI informatics platforms.

A second major innovation area is endoscopic tissue management. Modern closure devices include through-the-scope clips, larger defect-closure technologies, suturing platforms, tack-based systems, and other endoluminal tools that allow physicians to treat perforations, fistulas, post-resection defects, anastomotic problems, and selected leaks.

This is strategically important because reliable closure expands what physicians are willing to treat endoscopically. A hospital considering adoption of complex EMR, ESD, POEM, or full-thickness techniques evaluates not only the primary cutting or resection device but also whether effective rescue and closure technologies are available.

Pancreaticobiliary endoscopy is another premium innovation category. EUS has evolved from diagnostic imaging into an access platform for tissue acquisition, biliary drainage, gallbladder drainage, pseudocyst management, necrosectomy, and other interventions. Lumen-apposing metal stents have been particularly important because they facilitate transluminal drainage and access. Digital single-operator cholangioscopy similarly allows direct visualization of biliary anatomy rather than relying exclusively on fluoroscopic interpretation.

Endoscopic bariatric and metabolic intervention represents an emerging frontier. Endoscopic sleeve gastroplasty, intragastric balloons, transoral outlet reduction, and related procedures create a treatment category between pharmacological management and surgery. With more than 40% of U.S. adults affected by obesity, the addressable population is exceptionally large, but commercial growth will be determined by clinical durability, payer coverage, patient awareness, and positioning alongside rapidly expanding anti-obesity pharmacotherapy.

Single-use endoscopy is another important design cycle. The economic case differs substantially by procedure. High-volume screening centers with efficient reprocessing departments can spread reusable-scope costs across many procedures, while smaller or decentralized sites may value immediate availability and elimination of cleaning-related workflow. Duodenoscopy is particularly relevant because infection-prevention requirements and complex elevator mechanisms have created demand for alternative designs.

Advanced energy technologies are also expanding the therapeutic scope of GI endoscopy. Electrosurgical knives, bipolar and monopolar hemostasis, argon plasma coagulation, radiofrequency ablation, cryotherapy, and newer energy platforms support tissue resection, ablation, hemostasis, and treatment of Barrett’s-associated disease or other lesions. Increasingly, manufacturers are pairing energy delivery with procedural accessories, generators, pumps, and software rather than selling isolated instruments.

Finally, manufacturers are competing through training. Complex minimally invasive gastroenterology procedures have meaningful learning curves, making physician education commercially strategic. Simulation programs, proctorship, case observation, hands-on laboratories, reimbursement support, and procedure-development teams increasingly influence adoption. In high-complexity categories, a device without a strong training ecosystem may struggle even when technically differentiated.

 

Segmentation Insights

The U.S. Minimally Invasive Gastroenterology Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

Gastrointestinal Endoscopes and Visualization Systems

Gastrointestinal endoscopes and visualization platforms form the foundational capital-equipment segment. The category includes colonoscopes, gastroscopes, enteroscopes, duodenoscopes, video processors, light sources, displays, irrigation systems, insufflation equipment, image-management platforms, and related components.

Replacement cycles are increasingly driven by image quality, compatibility with advanced visualization modes, AI capability, ergonomic design, processor interoperability, maintenance requirements, and the ability to support therapeutic procedures. Large health systems increasingly evaluate endoscopy towers as enterprise infrastructure rather than isolated pieces of equipment.

Premium value is shifting toward platforms that improve mucosal visualization while reducing focal adjustment and supporting software upgrades. This favors manufacturers capable of combining optics, processors, artificial intelligence, service contracts, and physician training within one commercial relationship.

Endoscopic Therapeutic and Tissue-Management Devices

This segment includes snares, biopsy forceps, injection needles, retrieval devices, hemostasis clips, thermal devices, suturing systems, defect-closure technologies, resection instruments, electrosurgical knives, ablation devices, and related consumables.

It is among the most commercially attractive categories because most products generate recurring revenue on a per-procedure basis. Growth is increasingly linked to complex intervention rather than basic biopsy alone. EMR, ESD, POEM, advanced polypectomy, defect closure, endoscopic bariatric intervention, and endoscopic management of leaks can materially increase consumable value per procedure.

ERCP and Pancreaticobiliary Devices

ERCP products include guidewires, cannulation devices, sphincterotomes, extraction balloons, baskets, lithotripsy systems, pancreatic and biliary stents, cytology and biopsy tools, and accessories used to manage obstruction, stones, strictures, leaks, and malignancy.

This remains a high-value clinical segment because pancreaticobiliary procedures are complex, device-intensive, and heavily concentrated in specialist centers. Greater adoption of digital cholangioscopy and sophisticated stone-management devices is strengthening procedural capability while creating opportunities for premium consumables.

Endoscopic Ultrasound and Tissue-Acquisition Devices

The EUS category includes ultrasound endoscopes, processors, fine-needle aspiration and fine-needle biopsy devices, access needles, guidewires, drainage accessories, and products supporting therapeutic EUS.

Demand is being supported by pancreatic masses, subepithelial lesions, mediastinal or gastrointestinal lymph nodes, biliary disease, and pancreatic fluid collections. The shift from diagnostic EUS toward therapeutic EUS substantially increases the addressable device opportunity.

Gastrointestinal Stents, Dilation and Enteral Access Devices

This segment includes esophageal, duodenal, colonic, biliary and pancreatic stents; lumen-apposing metal stents; balloon and bougie dilation products; enteral feeding access devices; and selected decompression technologies.

The segment benefits from malignant obstruction, benign strictures, pancreaticobiliary disease, postoperative complications, feeding requirements, and increasing use of minimally invasive drainage. Stent innovation is focused on migration resistance, removability, delivery-system precision, radial force, conformability, and indication-specific design.

Capsule, Single-Use and Specialized Endoluminal Devices

Capsule endoscopy, disposable gastroscopes or duodenoscopes, single-use accessories, specialized endoluminal platforms, and emerging robotic or computer-assisted technologies form a smaller but faster-evolving product group.

Capsule endoscopy remains particularly relevant for small-bowel visualization and selected bleeding or Crohn’s disease investigations. Single-use technologies benefit from infection-control and workflow requirements, while advanced endoluminal systems are seeking to make complex procedures reproducible beyond a limited population of expert operators.

 

By Application

Colorectal Cancer Screening, Polypectomy and Lower-GI Disease

Colorectal applications represent the largest procedural opportunity. Screening colonoscopy, surveillance colonoscopy, polypectomy, biopsy, EMR, hemostasis, stricture management, IBD surveillance, and management of early colorectal neoplasia collectively create a large recurring device pool.

More than 155,000 new colorectal cancers were reported nationally in 2023, while screening recommendations covering adults beginning at age 45 have expanded the eligible population. Device adoption is increasingly influenced by adenoma detection, complete lesion removal, procedure time, post-polypectomy bleeding management, and reduction of repeat intervention.

Upper Gastrointestinal, GERD and Barrett’s-Related Disorders

Upper-GI applications include diagnostic gastroscopy, dysphagia evaluation, upper-GI bleeding, gastric lesions, esophageal strictures, Barrett’s esophagus, reflux-associated complications, varices, and selected early neoplastic lesions.

Demand spans high-volume diagnostic endoscopy and high-value therapy. Dilation products, ablation systems, hemostasis tools, biopsy devices, clips, suturing technologies, and stents contribute significantly to procedural revenue. Advanced centers increasingly manage superficial esophageal and gastric lesions with endoscopic resection rather than surgery in properly selected patients.

Pancreaticobiliary Disease

Pancreaticobiliary disease represents one of the highest-acuity applications. Pancreatic malignancy, biliary strictures, choledocholithiasis, obstructive jaundice, cholangitis, pancreatitis, and pancreatic fluid collections frequently require EUS, ERCP, drainage, tissue acquisition, lithotripsy, or stenting.

The high mortality associated with pancreatic cancer reinforces demand for more accurate tissue acquisition and disease staging. Therapeutic EUS and digital cholangioscopy are expanding the ability of gastroenterologists to intervene rather than simply diagnose.

Gastrointestinal Bleeding, Strictures and Luminal Complications

Acute GI bleeding remains a major hospital-based application because endoscopy can diagnose and treat the source during the same episode. Clips, injection needles, thermal devices, hemostatic powders or gels, Doppler-guided technologies, and endoscopic suturing can help avoid surgery or interventional radiology in appropriate patients.

Strictures, perforations, fistulas, postoperative leaks, and anastomotic complications similarly create opportunities for dilation, stenting, clipping, suturing, and endoluminal vacuum technologies.

Inflammatory Bowel and Small-Bowel Disease

Crohn’s disease, ulcerative colitis, obscure GI bleeding, small-bowel lesions, and related disorders generate recurring diagnostic and surveillance demand. Approximately one million Americans are estimated to live with Crohn’s disease and up to approximately 900,000 with ulcerative colitis.

The chronic nature of these diseases makes lifetime procedure utilization strategically important. Capsule endoscopy, enteroscopy, high-definition colonoscopy, biopsy devices, dilation technologies, and AI-supported image review may all benefit from improved disease monitoring.

Obesity and Metabolic Gastroenterology

Endoscopic sleeve gastroplasty, intragastric balloon placement, transoral outlet reduction, and emerging metabolic endoscopic therapies represent a comparatively small but high-growth application. The U.S. obesity prevalence of approximately 40.3% creates a very large theoretical patient pool.

Commercial penetration remains far below that potential because reimbursement, awareness, specialist availability, competition from medication, and long-term care pathways remain uneven. Nevertheless, the ability to perform incisionless or minimally invasive interventions in outpatient settings makes the segment strategically important through 2035.

 

By End User

Hospitals and Integrated Health Systems

Hospitals remain the largest end-user group by value because complex ERCP, EUS, GI bleeding management, advanced resection, pancreatic interventions, inpatient procedures, and high-risk cases remain concentrated in hospital settings. Large integrated delivery networks can negotiate enterprise contracts covering scopes, processors, therapeutic accessories, reprocessing, service, and capital upgrades.

Value-analysis committees increasingly demand clinical evidence and economic justification before adopting premium devices. Technologies that reduce surgery, hospitalization, procedure duration, scope downtime, or complications are consequently better positioned than products offering only incremental technical improvement.

Ambulatory Surgery Centers

ASCs represent the strongest structural outpatient growth opportunity. The U.S. had approximately 6,436 ASCs in 2024, reflecting an extensive national infrastructure for lower-cost procedural care.

High-volume GI-focused ASCs prioritize cost per procedure, room turnover, scope reliability, staff productivity, reprocessing throughput, and payer reimbursement. Colonoscopy and upper-GI endoscopy remain core procedures, while selected therapeutic cases are gradually migrating toward advanced outpatient centers.

Gastroenterology Practices and Independent Endoscopy Centers

Large gastroenterology groups increasingly control substantial regional procedure volumes. Consolidation and private-equity participation have strengthened the purchasing power of some physician organizations, allowing them to standardize equipment across multiple centers.

These buyers frequently have different priorities from tertiary hospitals. Predictable service, utilization economics, efficient capital financing, workflow simplicity, procedure documentation, and standardized training can be more important than access to the most sophisticated technology.

Academic Medical Centers and Advanced GI Referral Centers

Academic institutions and tertiary referral centers account for a disproportionate share of advanced endoscopy. ESD, POEM, therapeutic EUS, complex ERCP, pancreatic necrosectomy, bariatric endoscopy, difficult tissue closure, and clinical trials are heavily concentrated in these institutions.

Although their patient volume may be smaller than the national outpatient screening base, they strongly influence technology diffusion because they generate clinical evidence, train future gastroenterologists, and establish procedural standards.

Other Specialty and Care Settings

Community hospitals, Veterans Affairs facilities, cancer centers, and selected mobile or decentralized care settings comprise the remaining market. These sites create opportunities for portable, single-use, standardized, and tele-support-enabled technologies when access to specialized reprocessing or advanced endoscopy infrastructure is limited.

 

By Technology Type

Reusable Flexible Video Endoscopy

Reusable flexible endoscopy continues to account for the majority of U.S. procedure volume and installed capital. Mature reprocessing infrastructure and favorable economics at high utilization rates make reusable colonoscopes and gastroscopes difficult to displace in large endoscopy centers.

Competition is moving toward improved optics, processor capability, ergonomics, extended depth of field, imaging modes, service performance, and compatibility with AI.

Image-Enhanced and AI-Assisted Endoscopy

Image-enhanced endoscopy and computer-aided detection are expected to record some of the fastest technology adoption through 2035. AI can support lesion detection, procedure quality, documentation, and workflow standardization.

The longer-term opportunity extends beyond colorectal polyp detection. Software could eventually support lesion characterization, Barrett’s assessment, inflammatory disease scoring, procedure reporting, quality auditing, and automated video review.

Single-Use Endoscopy

Single-use endoscopes address infection-control, availability, repair, transport, and reprocessing issues. Growth is likely to be selective rather than universal.

Duodenoscopy represents a particularly important opportunity because the procedure requires a complex endoscope and is associated with stringent reprocessing expectations. Disposable upper-GI technologies can also serve urgent or decentralized settings where maintaining a reusable fleet is economically inefficient.

Advanced Therapeutic Endoscopy

Advanced therapeutic platforms encompass EMR, ESD, POEM, endoscopic suturing, full-thickness resection, hemostasis, ablation, transluminal drainage, and bariatric endoscopy.

This is expected to be one of the most important value-growth categories because advanced interventions frequently create a direct alternative to surgery. As specialist training expands, techniques currently concentrated in major academic centers can move into large regional health systems.

EUS, Cholangioscopy and Capsule-Based Visualization

EUS and cholangioscopy extend visualization beyond conventional luminal endoscopy and increasingly combine diagnosis with therapy. Capsule imaging addresses anatomical areas that conventional endoscopes cannot easily access.

These technologies will gain value through better image quality, improved tissue acquisition, miniaturization, AI-supported interpretation, and greater therapeutic integration.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Minimally Invasive Gastroenterology Devices Market is geographically divided into the South, West, Northeast, and Midwest. Regional performance depends on population, age profile, gastrointestinal disease burden, colorectal screening activity, obesity prevalence, gastroenterologist density, ASC penetration, academic medical center concentration, payer mix, hospital consolidation, and adoption of advanced endoscopy.

The South is estimated to represent the largest regional market at approximately USD 2.80 billion in 2025, while the West is expected to record the fastest growth. The Northeast has the highest concentration of complex academic gastroenterology programs, while the Midwest provides a substantial and comparatively stable base of screening, community GI, IBD, and advanced referral demand.

South

The South includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma and the District of Columbia. The region represented an estimated USD 2.80 billion in 2025 and is projected to approach USD 6.08 billion by 2035, equivalent to an approximately 8.1% regional CAGR.

Texas and Florida form the core of the Southern opportunity. Texas combines one of the country’s largest populations with extensive hospital systems, freestanding GI centers, academic programs, and large metropolitan healthcare markets in Houston, Dallas–Fort Worth, Austin and San Antonio. Its scale supports virtually every device category, from high-volume screening colonoscopy consumables to advanced EUS, ERCP, bariatric endoscopy, and complex tissue-management technologies.

Florida is especially important because its older population increases demand for colorectal surveillance, biliary intervention, pancreatic disease management, GI bleeding treatment, and therapeutic upper-GI endoscopy. The state also has a large outpatient procedural infrastructure, making ASC-targeted technologies commercially important.

North Carolina, Georgia, Virginia, Maryland and Tennessee form another high-value corridor. Charlotte, Raleigh-Durham, Atlanta, Richmond, Northern Virginia, Baltimore and Nashville support sophisticated provider networks and academic referral systems. North Carolina’s research infrastructure is favorable for advanced GI technology evaluation, while Nashville’s healthcare-services ecosystem provides vendors access to major hospital and ambulatory operators.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia and Oklahoma present a different commercial profile. Chronic disease and obesity burdens can be high, but advanced specialist availability is less uniformly distributed. Manufacturers therefore face both an access challenge and a market opportunity. Regional referral hubs require premium endoscopic intervention platforms, whereas community facilities can favor simplified systems, single-use devices, and technologies that reduce transfer to tertiary hospitals.

By 2035, the South should remain the largest regional market because it combines population growth, high obesity prevalence, expanding Medicare populations, hospital investment, and continuing growth in outpatient procedural infrastructure.

West

The West includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii. The region accounted for an estimated USD 1.67 billion in 2025 and is projected to reach approximately USD 3.90 billion by 2035, representing the fastest regional CAGR at approximately 8.9%.

California dominates the regional market. Its combination of population scale, high-volume health systems, large academic programs, medtech innovation, venture investment, diverse payer environments, and extensive specialist networks makes it particularly attractive for premium gastrointestinal technology.

Los Angeles, San Diego, the San Francisco Bay Area and Sacramento contain hospitals capable of supporting advanced EUS, therapeutic ERCP, complex colorectal resection, endoscopic suturing, bariatric endoscopy, and AI-assisted colonoscopy. California is also likely to remain an important early-adoption market for software-supported endoscopy and data-driven procedural quality tools.

Arizona and Nevada are strong demographic growth markets. Aging populations and rapid metropolitan expansion around Phoenix, Tucson and Las Vegas are increasing demand for colonoscopy, upper-GI endoscopy, biliary intervention, and cancer-related procedures. Obesity and metabolic disease also make these states relevant to future endobariatric adoption.

Colorado and Utah combine growing populations with integrated delivery networks and sophisticated specialty programs. Denver and Salt Lake City function as referral markets for surrounding mountain states, increasing their importance beyond resident population alone.

Washington and Oregon are attractive for digital workflow, connected care, advanced imaging, and enterprise procurement. Seattle’s clinical and technology ecosystem makes the market relevant for AI-enabled endoscopy, while major Portland-area systems provide substantial GI procedure volumes.

Idaho, Montana, Wyoming, New Mexico and Alaska have smaller absolute markets but illustrate the access challenge created by geography. Technologies that reduce transfers, improve specialist productivity, provide portable visualization, or simplify equipment availability may have disproportionate value in these states. Hawaii similarly has unique logistical considerations that can make inventory, repair cycles and device availability strategically significant.

The West is expected to gain market share through 2035 because it combines population migration, technological early adoption, rapid ambulatory expansion, and strong receptivity to AI and single-use technology.

Northeast

The Northeast includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire and Maine. The regional market was approximately USD 1.82 billion in 2025 and is forecast to reach about USD 3.73 billion by 2035.

New York is the largest state opportunity. New York City contains a dense ecosystem of academic hospitals, cancer centers, community systems and independent gastroenterology practices, while Upstate New York adds large regional health networks. Demand spans routine colonoscopy through complex pancreaticobiliary and third-space endoscopy.

Massachusetts is smaller by population but highly influential. Boston’s academic medical centers participate in clinical research, physician training and adoption of complex procedures. Technologies validated in these institutions can influence purchasing patterns well beyond the state.

Pennsylvania provides a large and diverse procedural market across Philadelphia, Pittsburgh and multiple regional health systems. Its mix of major academic centers and community hospitals creates opportunities across the entire product spectrum.

New Jersey and Connecticut benefit from high insurance coverage, proximity to major academic markets and substantial specialist density. New Jersey also supports significant outpatient procedure volumes, creating strong competition for ASC-oriented endoscopy systems and consumables.

Maine, New Hampshire, Vermont and Rhode Island are smaller markets. Their strategic characteristics include regional referral structures, aging populations, rural access considerations in northern New England, and demand for technologies that allow complex care to remain within regional health systems.

Growth in the Northeast is expected to remain slightly below the West and South because population growth is slower and the endoscopy infrastructure is already mature. However, revenue per advanced procedure is likely to remain high due to complex case mix, premium technology adoption, academic influence and rigorous quality standards.

Midwest

The Midwest includes Illinois, Ohio, Michigan, Minnesota, Indiana, Wisconsin, Missouri, Iowa, Kansas, Nebraska, North Dakota and South Dakota. The regional market is estimated at USD 1.29 billion in 2025 and could reach approximately USD 2.73 billion by 2035.

Illinois represents one of the region’s largest markets, led by Chicago’s academic institutions, major health systems and large outpatient GI infrastructure. Advanced pancreaticobiliary care, cancer screening, IBD management, and sophisticated therapeutic endoscopy support broad device demand.

Ohio has a particularly strong medical referral infrastructure. Major systems in Cleveland, Columbus and Cincinnati support advanced GI procedures and physician training. The state’s combination of large population centers and regional healthcare networks makes enterprise contracting an important commercial route.

Michigan provides substantial demand across Detroit, Ann Arbor, Grand Rapids and other urban centers. Colorectal disease, chronic GI care and hospital-based advanced procedures contribute to recurring utilization.

Minnesota is strategically influential because of its medical-technology ecosystem and high-quality specialty care infrastructure. Minneapolis–St. Paul supports advanced endoscopy and serves as a technology evaluation market. Wisconsin similarly benefits from integrated healthcare organizations with strong procurement discipline.

Indiana and Missouri contain important regional referral markets around Indianapolis, St. Louis and Kansas City. Iowa, Kansas and Nebraska provide stable screening and therapeutic demand, with major academic and regional centers acting as referral hubs for surrounding rural areas.

North Dakota and South Dakota are smaller markets, but long travel distances strengthen the value proposition for regional centers that can perform advanced procedures locally. Equipment reliability, service coverage, remote clinical support, portable platforms, and efficient inventory models are therefore important competitive factors.

The Midwest is expected to remain a durable market rather than the fastest-growing one. Vendors that offer reliable service, clinically proven consumables, attractive contracting, strong physician education and efficient standardization across health-system networks are likely to perform well.

 

Key Market Players

The U.S. Minimally Invasive Gastroenterology Devices competitive landscape is moderately consolidated in endoscopy capital equipment but considerably more fragmented across therapeutic consumables and emerging technologies.

Olympus remains structurally important because of its extensive flexible-endoscopy installed base and advanced visualization portfolio. Boston Scientific has one of the broadest interventional gastroenterology portfolios spanning ERCP, cholangioscopy, stents, lumen-apposing stents, hemostasis, tissue management, endoscopic suturing, and bariatric endoscopy. Medtronic combines established GI products with a strategic position in AI-assisted colonoscopy through the GI Genius ecosystem. Fujifilm is expanding its U.S. position through advanced visualization and AI-enabled endoscopy, while PENTAX Medical remains a significant flexible endoscopy competitor.

Cook Medical maintains strong relevance in pancreaticobiliary intervention, GI stenting, access, and endotherapy. CONMED competes across endoscopic accessories and electrosurgical technologies, while STERIS combines procedure devices with reprocessing and infection-prevention capabilities. Ambu represents an important challenger in single-use endoscopy.

Other relevant competitors and innovators include Merit Medical Systems, Micro-Tech Endoscopy USA, ERBE USA, B. Braun, Cardinal Health, Avanos Medical, Taewoong Medical, Creo Medical, CapsoVision, AnX Robotica, EndoGastric Solutions, Laborie/GI Supply, Lumendi, Fractyl Health, and emerging flexible or robotic endoluminal technology developers.

Accordingly, approximately 20–25 relevant companies shaping the U.S. competitive ecosystem include Olympus Corporation, Boston Scientific Corporation, Medtronic, FUJIFILM Healthcare Americas, PENTAX Medical, Cook Medical, CONMED Corporation, STERIS, Ambu, Merit Medical Systems, Micro-Tech Endoscopy USA, ERBE USA, B. Braun, Cardinal Health, Avanos Medical, Taewoong Medical, Creo Medical, CapsoVision, AnX Robotica, EndoGastric Solutions, Laborie/GI Supply, Lumendi, Fractyl Health, and other emerging advanced-endoscopy platform developers.

Competitive differentiation through 2035 will increasingly depend on platform breadth, installed-base leverage, physician training, FDA clearances, interoperability, contracting flexibility, clinical evidence, reprocessing strategy, reimbursement support, and the ability to demonstrate measurable economic value to hospitals and ambulatory centers.

Large companies possess an advantage where systems prefer bundled capital and consumable agreements. Smaller innovators can nevertheless capture substantial value by addressing unresolved procedural limitations such as difficult tissue closure, more precise lesion resection, single-use workflow, advanced metabolic intervention, or improved access to complex anatomy.

 

Recent Developments

The U.S. market entered a new imaging cycle in 2025 when Olympus received FDA 510(k) clearance for its EZ1500-series gastroscope and colonoscope incorporating extended-depth-of-field technology as part of the EVIS X1 platform. The technology is designed to maintain a broader area of the endoscopic image in focus, potentially reducing the need for repeated focal adjustment during mucosal inspection.

Artificial intelligence competition accelerated during 2024. Fujifilm received U.S. 510(k) clearance for CAD EYE, an AI-assisted system designed for real-time detection of colonic mucosal lesions. Supporting clinical evidence cited by the company demonstrated higher adenoma detection measures compared with conventional high-definition colonoscopy without increasing procedure time.

Medtronic also advanced the GI Genius ecosystem in 2024 with ColonPRO software. The update incorporated a larger training dataset, workflow enhancements and a reported reduction in false-positive alerts. Medtronic’s broader strategy is moving GI Genius from a single-purpose detection product toward an extensible AI platform supporting additional applications and integration with endoscopy documentation workflows.

Endobariatric competition is also entering a more commercial phase. Following Boston Scientific’s acquisition of Apollo Endosurgery in 2023, the company integrated endoscopic suturing and bariatric technologies into its broader endoscopy portfolio. In 2025, Boston Scientific introduced Endura Weight Loss Solutions in the U.S., highlighting endoscopic sleeve gastroplasty and intragastric balloon procedures as minimally invasive obesity-management options.

Single-use endoscopy continues to evolve as manufacturers address infection prevention and availability. Sterile disposable duodenoscopes and gastroscopes are increasingly positioned as complements rather than universal replacements for reusable systems. Their strongest clinical economics are emerging in high-risk patients, urgent procedures, overflow capacity, decentralized locations, or situations in which reprocessing complexity materially affects workflow.

FDA attention to endoscope reprocessing also continues to shape purchasing behavior. The regulatory emphasis on validated reprocessing procedures, enhanced device designs and appropriate sterilization reinforces the value of infection-prevention features during hospital procurement.

Therapeutic endoscopy is simultaneously becoming more sophisticated. Tissue closure, EUS-guided intervention, cholangioscopy, bariatric endoscopy, endoluminal defect management, and complex lesion resection are creating a competitive environment in which gastroenterology increasingly resembles an interventional procedural specialty rather than a predominantly diagnostic one.

 

Conclusion

The U.S. Minimally Invasive Gastroenterology Devices Market Size & Share is positioned to increase from approximately USD 7.58 billion in 2025 to USD 16.44 billion by 2035, representing a forecast CAGR of 8.05% during 2026–2035.

The central growth story is not simply rising endoscopy volume. Market value is being reshaped by the increasing sophistication of what can be accomplished through an endoscope. Advanced visualization, artificial intelligence, EUS-guided intervention, pancreaticobiliary therapy, tissue resection, endoscopic closure, bariatric endoscopy, single-use devices, and complex hemostasis are moving more gastrointestinal treatment into minimally invasive procedural pathways.

Colorectal screening will remain the largest volume foundation. Pancreaticobiliary disease and therapeutic EUS will provide high-value procedural growth. Advanced tissue management and endoluminal surgery will expand the range of conditions treated without conventional surgery. AI will increasingly influence capital-equipment replacement decisions, while outpatient migration will make cost per procedure, reliability and workflow efficiency more important to product adoption.

Regionally, the South is expected to retain the largest market position, supported by Texas, Florida and rapidly expanding southeastern health systems. The West should achieve the fastest growth, driven by California’s technology-intensive healthcare environment and population growth in Arizona, Nevada, Colorado and Utah. The Northeast will remain critical for complex procedures, clinical evidence and early technology adoption, while the Midwest will provide a stable base of screening and advanced referral demand.

For manufacturers, investors, distributors and healthcare strategists, the key question through 2035 is not whether U.S. gastroenterology becomes more minimally invasive. The decisive questions are which procedures migrate away from surgery, which technologies meaningfully improve procedure economics, which devices can diffuse beyond expert academic centers, and which companies can create scalable ecosystems around visualization, intervention, data and physician training.

Companies capable of demonstrating better lesion detection, reliable therapeutic performance, fewer complications, reduced procedural time, improved endoscopy-suite productivity, lower reprocessing burden, shorter patient recovery and credible total-cost-of-care improvement will be best positioned to defend premium pricing and capture the next phase of U.S. minimally invasive gastroenterology device growth.

 

TABLE OF CONTENT

1. U.S. Minimally Invasive Gastroenterology Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Gastrointestinal Endoscopy and Therapeutic Device Manufacturers
1.6.2. Component, Optics, Electronics and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Gastroenterology Practices and Advanced Endoscopy Centers
1.6.5. Ambulatory Surgery Centers and Independent Endoscopy Centers
1.6.6. Group Purchasing Organizations, Distributors and Specialty Suppliers
1.6.7. Payers, Regulators and Gastroenterology Clinical Decision-Makers

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, device inclusion criteria, and stakeholder ecosystem so clients understand how the U.S. minimally invasive gastroenterology devices market is measured and validated.

2. U.S. Minimally Invasive Gastroenterology Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.7.1. AI-Assisted Colonoscopy and Image-Enhanced Endoscopy
2.7.2. Therapeutic Endoscopic Ultrasound
2.7.3. Advanced Endoscopic Tissue Resection and Closure
2.7.4. Pancreaticobiliary Intervention and Digital Cholangioscopy
2.7.5. Single-Use Endoscopy
2.7.6. Endoscopic Bariatric and Metabolic Therapies

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, procedure-demand trends, competitive intensity, and the highest-value minimally invasive gastroenterology opportunities through 2035.

3. U.S. Minimally Invasive Gastroenterology Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Colorectal Cancer Screening and Surveillance
3.1.2. Shift from Diagnostic to Therapeutic Gastrointestinal Endoscopy
3.1.3. Growing Burden of Pancreatic, Biliary and Chronic Gastrointestinal Disease
3.1.4. Increasing Adoption of AI-Assisted and Image-Enhanced Endoscopy
3.1.5. Migration of Gastrointestinal Procedures to Ambulatory Settings
3.1.6. Rising Demand for Minimally Invasive Alternatives to Gastrointestinal Surgery
3.1.7. Increasing Focus on Endoscope Reprocessing and Infection Prevention
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Endoscopy Platforms
3.2.2. Reimbursement Variability for Emerging Therapeutic Endoscopy Procedures
3.2.3. Endoscope Reprocessing, Maintenance and Repair Burden
3.2.4. Limited Availability of Advanced Endoscopists
3.2.5. Procedure Complexity and Physician Learning Curves
3.2.6. Price Pressure on High-Volume Disposable Endotherapy Products
3.3. Opportunities and Their Impact Analysis
3.3.1. Therapeutic EUS and Lumen-Apposing Metal Stent Adoption
3.3.2. AI-Based Polyp Detection and Lesion Characterization
3.3.3. Endoscopic Submucosal Dissection and Third-Space Endoscopy
3.3.4. Endoscopic Suturing and Full-Thickness Defect Closure
3.3.5. Endoscopic Bariatric and Metabolic Procedures
3.3.6. Single-Use and Hybrid Disposable Endoscope Platforms
3.3.7. Advanced GI Procedures in Ambulatory Surgery Centers
3.4. Challenges and Their Impact Analysis
3.4.1. Clinical Evidence Requirements for New Endoluminal Technologies
3.4.2. Standardization of Complex Advanced Endoscopy Procedures
3.4.3. Supply-Chain Dependence for Precision Optics and Electronic Components
3.4.4. Balancing Single-Use Economics with Sustainability Requirements
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Procedure Room Turnover Economics
3.6.2. Reprocessing Cost per Procedure
3.6.3. Disposable Device Utilization per Case
3.6.4. Avoided Surgery and Hospitalization Economics
3.6.5. Endoscopy Suite Staffing and Productivity
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Endoscopy Tower Replacement Cycles
3.7.2. Value Analysis Committee Requirements
3.7.3. Installed-Base and Platform Standardization Effects
3.7.4. Service Contract and Maintenance Economics
3.7.5. Capital-versus-Disposable Purchasing Models

What this section provides: This section explains the clinical, economic, reimbursement, procedural, infection-control, and operational factors shaping U.S. demand while identifying the market’s strongest growth opportunities and execution risks.

4. U.S. Minimally Invasive Gastroenterology Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.3.1. Capital Endoscopy Platform Pricing
4.3.2. Therapeutic Disposable Pricing
4.3.3. Service, Maintenance and Reprocessing Cost Trends
4.3.4. ASC versus Hospital Purchasing Economics
4.4. Value Chain & Supply Chain Analysis
4.4.1. Precision Optics and Imaging Components
4.4.2. Endoscope Manufacturing and Assembly
4.4.3. Therapeutic Accessory Manufacturing
4.4.4. Distribution and GPO Channels
4.4.5. Hospital and Ambulatory End Users
4.5. Impact of Digitalization, AI and Gastrointestinal Informatics
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. 510(k) Pathway
4.7.2. De Novo Classification
4.7.3. Premarket Approval Considerations
4.7.4. Endoscope Reprocessing and Infection-Control Requirements
4.7.5. Software as a Medical Device and AI Considerations
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Medicare Hospital Outpatient Reimbursement
4.8.2. Ambulatory Surgical Center Reimbursement
4.8.3. Professional Fee Considerations
4.8.4. Coverage Considerations for Emerging Therapeutic Endoscopy
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Gastrointestinal Cancer Screening Programs
4.11. Impact of Escalating Geopolitical Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Benefit Assessment
4.12.2. Cost per Procedure Assessment
4.12.3. Procedure Throughput Impact
4.12.4. Infection-Control and Reprocessing Impact
4.12.5. Reimbursement and ROI Assessment

What this section provides: This section gives clients a complete view of regulation, reimbursement, pricing, supply chains, digitalization, AI adoption, infection prevention, purchasing economics, and external forces affecting U.S. minimally invasive gastroenterology devices.

5. U.S. Minimally Invasive Gastroenterology Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Gastrointestinal Endoscopes and Visualization Systems
5.1.2.1. Colonoscopes
5.1.2.2. Gastroscopes
5.1.2.3. Duodenoscopes
5.1.2.4. Enteroscopes
5.1.2.5. Video Processors and Light Sources
5.1.2.6. Endoscopy Displays and Image-Management Systems
5.1.2.7. Insufflation, Irrigation and Ancillary Visualization Systems
5.1.3. Endoscopic Therapeutic and Tissue-Management Devices
5.1.3.1. Polypectomy Snares
5.1.3.2. Biopsy Forceps
5.1.3.3. Injection Needles
5.1.3.4. Hemostasis Clips
5.1.3.5. Thermal Hemostasis and Coagulation Devices
5.1.3.6. Endoscopic Resection Devices
5.1.3.7. Endoscopic Suturing and Closure Devices
5.1.3.8. Retrieval and Foreign-Body Removal Devices
5.1.3.9. Endoscopic Ablation Devices
5.1.4. ERCP and Pancreaticobiliary Devices
5.1.4.1. Guidewires
5.1.4.2. Sphincterotomes and Cannulation Devices
5.1.4.3. Stone Extraction Balloons
5.1.4.4. Retrieval Baskets
5.1.4.5. Lithotripsy Devices
5.1.4.6. Biliary and Pancreatic Stents
5.1.4.7. Cholangioscopy Systems and Accessories
5.1.5. Endoscopic Ultrasound and Tissue-Acquisition Devices
5.1.5.1. EUS Endoscopes
5.1.5.2. EUS Processors
5.1.5.3. Fine-Needle Aspiration Devices
5.1.5.4. Fine-Needle Biopsy Devices
5.1.5.5. EUS-Guided Access and Drainage Devices
5.1.6. Gastrointestinal Stents, Dilation and Enteral Access Devices
5.1.6.1. Esophageal Stents
5.1.6.2. Duodenal and Enteral Stents
5.1.6.3. Colonic Stents
5.1.6.4. Lumen-Apposing Metal Stents
5.1.6.5. Balloon Dilators
5.1.6.6. Bougie Dilators
5.1.6.7. Enteral Feeding Access Devices
5.1.7. Capsule, Single-Use and Specialized Endoluminal Devices
5.1.7.1. Capsule Endoscopy Systems
5.1.7.2. Single-Use Gastroscopes
5.1.7.3. Single-Use Duodenoscopes
5.1.7.4. Disposable Endoscopy Components
5.1.7.5. Specialized Endoluminal Platforms
5.1.7.6. Emerging Robotic Endoscopy Devices

What this section provides: This section identifies the product categories and individual device classes expected to generate the strongest revenue contribution, recurring disposable demand, and innovation-led growth through 2035.

6. U.S. Minimally Invasive Gastroenterology Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Colorectal Cancer Screening, Polypectomy and Lower-GI Disease
6.1.2.1. Screening Colonoscopy
6.1.2.2. Surveillance Colonoscopy
6.1.2.3. Polypectomy
6.1.2.4. Endoscopic Mucosal Resection
6.1.2.5. Endoscopic Submucosal Dissection
6.1.2.6. Inflammatory Bowel Disease Surveillance
6.1.3. Upper Gastrointestinal, GERD and Barrett’s-Related Disorders
6.1.3.1. Diagnostic Upper-GI Endoscopy
6.1.3.2. Dysphagia and Esophageal Stricture Management
6.1.3.3. Barrett’s Esophagus Diagnosis and Ablation
6.1.3.4. Upper-GI Neoplasia Management
6.1.3.5. Esophageal and Gastric Stenting
6.1.4. Pancreaticobiliary Disease
6.1.4.1. Biliary Obstruction
6.1.4.2. Choledocholithiasis
6.1.4.3. Pancreatic Mass Diagnosis
6.1.4.4. Pancreatitis and Pancreatic Fluid Collections
6.1.4.5. Biliary and Pancreatic Stricture Management
6.1.4.6. Cholangioscopy-Guided Diagnosis and Therapy
6.1.5. Gastrointestinal Bleeding, Strictures and Luminal Complications
6.1.5.1. Upper-GI Bleeding
6.1.5.2. Lower-GI Bleeding
6.1.5.3. Gastrointestinal Strictures
6.1.5.4. Perforation and Fistula Closure
6.1.5.5. Post-Surgical Leaks and Anastomotic Complications
6.1.6. Inflammatory Bowel and Small-Bowel Disease
6.1.6.1. Crohn’s Disease
6.1.6.2. Ulcerative Colitis
6.1.6.3. Obscure Gastrointestinal Bleeding
6.1.6.4. Small-Bowel Lesions
6.1.6.5. Capsule-Based Small-Bowel Evaluation
6.1.7. Obesity and Metabolic Gastroenterology
6.1.7.1. Endoscopic Sleeve Gastroplasty
6.1.7.2. Intragastric Balloon Procedures
6.1.7.3. Transoral Outlet Reduction
6.1.7.4. Revision of Prior Bariatric Procedures
6.1.7.5. Emerging Endoscopic Metabolic Therapies

What this section provides: This section analyzes device demand by clinical use case and helps clients identify applications where procedure growth, clinical unmet need, reimbursement potential, and minimally invasive substitution are strongest.

7. U.S. Minimally Invasive Gastroenterology Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Large Academic Hospitals
7.1.2.2. Community Hospitals
7.1.2.3. Integrated Delivery Networks
7.1.3. Ambulatory Surgery Centers
7.1.3.1. Gastroenterology-Focused ASCs
7.1.3.2. Multispecialty ASCs
7.1.4. Gastroenterology Practices and Independent Endoscopy Centers
7.1.4.1. Independent Gastroenterology Groups
7.1.4.2. Consolidated Gastroenterology Platforms
7.1.4.3. Physician-Owned Endoscopy Centers
7.1.5. Academic Medical Centers and Advanced GI Referral Centers
7.1.5.1. Advanced Endoscopy Programs
7.1.5.2. Pancreaticobiliary Referral Centers
7.1.5.3. Gastrointestinal Oncology Centers
7.1.5.4. IBD Specialty Centers
7.1.6. Other Specialty and Care Settings
7.1.6.1. Veterans Affairs Facilities
7.1.6.2. Cancer Centers
7.1.6.3. Specialty Hospitals
7.1.6.4. Decentralized and Rural Procedure Settings

What this section provides: This section explains which care environments drive capital equipment procurement, therapeutic consumable utilization, outpatient procedure migration, advanced endoscopy adoption, and recurring device demand.

8. U.S. Minimally Invasive Gastroenterology Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Reusable Flexible Video Endoscopy
8.1.2.1. High-Definition Video Endoscopy
8.1.2.2. Advanced Optical Imaging
8.1.2.3. Extended-Depth-of-Field Imaging
8.1.3. Image-Enhanced and AI-Assisted Endoscopy
8.1.3.1. Computer-Aided Polyp Detection
8.1.3.2. Computer-Aided Lesion Characterization
8.1.3.3. Virtual Chromoendoscopy
8.1.3.4. AI-Based Procedure Documentation and Quality Analytics
8.1.4. Single-Use Endoscopy
8.1.4.1. Single-Use Duodenoscopy
8.1.4.2. Single-Use Gastroscopy
8.1.4.3. Disposable Endoscope Components
8.1.5. Advanced Therapeutic Endoscopy
8.1.5.1. Endoscopic Mucosal Resection
8.1.5.2. Endoscopic Submucosal Dissection
8.1.5.3. Peroral Endoscopic Myotomy
8.1.5.4. Endoscopic Suturing and Closure
8.1.5.5. Endoscopic Full-Thickness Resection
8.1.5.6. Endoscopic Bariatric Intervention
8.1.6. EUS, Cholangioscopy and Capsule-Based Visualization
8.1.6.1. Diagnostic EUS
8.1.6.2. Therapeutic EUS
8.1.6.3. Digital Cholangioscopy
8.1.6.4. Capsule Endoscopy
8.1.6.5. AI-Assisted Capsule Image Interpretation

What this section provides: This section evaluates the technology platforms reshaping minimally invasive gastroenterology, including reusable endoscopy, AI-enabled imaging, disposable scopes, therapeutic endoscopy, EUS, cholangioscopy, and capsule-based visualization.

9. U.S. Minimally Invasive Gastroenterology Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Procurement
9.1.2.2. Therapeutic Disposable Procurement
9.1.2.3. Service and Maintenance Contracts
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Vendor Standardization
9.1.3.2. Enterprise Endoscopy Platform Agreements
9.1.3.3. Volume-Based Disposable Contracts
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Agreements
9.1.4.2. Regional GPO Agreements
9.1.4.3. Aggregated Gastroenterology Purchasing Programs
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. National Medical Device Distributors
9.1.5.2. Specialty Gastroenterology Distributors
9.1.5.3. Procedure-Specific Supply Channels
9.1.6. Ambulatory and Physician-Group Procurement
9.1.6.1. ASC Direct Procurement
9.1.6.2. Independent Gastroenterology Group Purchasing
9.1.6.3. Consolidated Gastroenterology Platform Procurement
9.1.6.4. Capital Leasing and Managed Equipment Models

What this section provides: This section explains how minimally invasive gastroenterology devices are purchased across U.S. hospitals, IDNs, GPOs, gastroenterology groups, distributors, and ASCs, including vendor standardization and contracting dynamics.

10. U.S. Minimally Invasive Gastroenterology Devices Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Gastrointestinal Procedure Volume Analysis
10.1.4. Regional Endoscopy Suite and ASC Infrastructure Analysis
10.1.5. Regional Gastroenterologist and Advanced Endoscopist Availability
10.1.6. Regional Colorectal Screening and GI Disease Burden Analysis
10.1.7. Regional Reimbursement and Procurement Dynamics
10.1.8. Regional Advanced Endoscopy Adoption Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers comprehensive regional and state-level intelligence across all 50 states, enabling clients to identify gastrointestinal procedure-volume hubs, advanced endoscopy adoption hotspots, ASC opportunities, regional procurement patterns, and priority commercial territories.

11. U.S. Minimally Invasive Gastroenterology Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.3.1. Flexible Endoscopy Platforms
11.3.2. Therapeutic Endoscopy Devices
11.3.3. ERCP and Pancreaticobiliary Devices
11.3.4. EUS and Tissue Acquisition
11.3.5. AI-Assisted Endoscopy
11.3.6. Single-Use Endoscopy
11.3.7. Endoscopic Bariatric and Advanced Endoluminal Technologies
11.4. Company Profiles
11.4.1. Olympus Corporation
11.4.2. Boston Scientific Corporation
11.4.3. Medtronic
11.4.4. FUJIFILM Healthcare Americas Corporation
11.4.5. PENTAX Medical
11.4.6. Cook Medical
11.4.7. CONMED Corporation
11.4.8. STERIS
11.4.9. Ambu A/S
11.4.10. Merit Medical Systems
11.4.11. Micro-Tech Endoscopy USA
11.4.12. ERBE USA
11.4.13. B. Braun
11.4.14. Cardinal Health
11.4.15. Avanos Medical
11.4.16. Taewoong Medical
11.4.17. Creo Medical
11.4.18. CapsoVision
11.4.19. AnX Robotica
11.4.20. EndoGastric Solutions
11.4.21. Ovesco Endoscopy USA
11.4.22. Lumendi
11.4.23. Fractyl Health
11.4.24. EndoQuest Robotics
11.4.25. Laborie Medical Technologies

Note: Each company profile will include company overview, U.S. minimally invasive gastroenterology device portfolio, product positioning, U.S. commercial strategy, financial positioning where available, clinical pipeline, FDA and regulatory updates, partnerships, acquisitions, physician-training strategy, and recent developments.

What this section provides: This section provides competitor benchmarking, market-share visibility, portfolio positioning, installed-base analysis, innovation direction, acquisition activity, and strategic intelligence on established and emerging minimally invasive gastroenterology device companies.

12. U.S. Minimally Invasive Gastroenterology Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Detection and Lesion Characterization
12.2.2. Therapeutic EUS and Advanced Translumenal Intervention
12.2.3. Robotic and Computer-Assisted Endoluminal Platforms
12.2.4. Third-Space Endoscopy and Advanced Tissue Resection
12.2.5. Single-Use Gastrointestinal Endoscopy
12.2.6. Endoscopic Bariatric and Metabolic Therapies
12.2.7. Advanced Tissue Closure and Endoscopic Suturing
12.2.8. Digital Cholangioscopy and Pancreaticobiliary Navigation
12.3. Emerging Business Trends
12.3.1. Gastroenterology Practice Consolidation
12.3.2. ASC Procedure Migration
12.3.3. Platform-Based Endoscopy Purchasing
12.3.4. Recurring Software and AI Revenue Models
12.3.5. Capital Equipment Leasing and Managed Service Models
12.3.6. Integrated Capital-and-Consumable Contracting
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Unmet Need
12.5.3. Reimbursement Readiness
12.5.4. Competitive Intensity
12.5.5. Physician Adoption Complexity
12.5.6. Scalability Potential

What this section provides: This section prepares clients for future technology shifts, changing procedure pathways, evolving business models, investment opportunities, and market adoption scenarios that could reshape minimally invasive gastroenterology through 2035.

13. U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations

13.1. Recommendations for Device Manufacturers
13.1.1. Capital Platform Strategy
13.1.2. Therapeutic Consumable Portfolio Strategy
13.1.3. AI and Software Integration Strategy
13.1.4. Physician Training and Clinical Adoption Strategy
13.2. Recommendations for Hospitals and Health Systems
13.2.1. Endoscopy Platform Standardization
13.2.2. Advanced Endoscopy Program Development
13.2.3. Reprocessing and Infection-Control Optimization
13.2.4. Total Procedure Cost Evaluation
13.3. Recommendations for Investors and Private Equity Firms
13.3.1. High-Growth Technology Screening
13.3.2. Gastroenterology Platform Consolidation Opportunities
13.3.3. Therapeutic Endoscopy Investment Priorities
13.4. Recommendations for Distributors and Channel Partners
13.4.1. Regional Commercial Prioritization
13.4.2. Specialty Product Portfolio Expansion
13.4.3. ASC and Independent GI Practice Channel Strategy
13.5. Recommendations for New Entrants and Startups
13.5.1. Unmet Clinical Need Identification
13.5.2. FDA Pathway Planning
13.5.3. Clinical Evidence Generation
13.5.4. Physician KOL Development
13.6. Go-to-Market Strategy Considerations
13.6.1. Hospital and IDN Strategy
13.6.2. ASC Commercial Strategy
13.6.3. Gastroenterology Group Strategy
13.6.4. Reimbursement Support Strategy
13.7. Product Positioning and Portfolio Expansion Guidance
13.7.1. Build-versus-Buy Considerations
13.7.2. Adjacent Device Category Expansion
13.7.3. Acquisition and Partnership Opportunities
13.7.4. Platform Bundling Opportunities

What this section provides: This section converts market intelligence into actionable recommendations for manufacturers, hospitals, investors, distributors, and new entrants covering commercialization, portfolio expansion, procurement, channel strategy, and competitive differentiation.

14. U.S. Minimally Invasive Gastroenterology Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting boundaries, data-use conditions, legal considerations, and third-party data assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Minimally Invasive Gastroenterology Devices Market: Market Definition and Scope
TABLE 3: U.S. Minimally Invasive Gastroenterology Devices Market: Research Methodology Framework
TABLE 4: U.S. Minimally Invasive Gastroenterology Devices Market: Key Assumptions
TABLE 5: U.S. Minimally Invasive Gastroenterology Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Minimally Invasive Gastroenterology Devices Market: Stakeholder Analysis
TABLE 7: U.S. Minimally Invasive Gastroenterology Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Minimally Invasive Gastroenterology Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Minimally Invasive Gastroenterology Devices Market: Market Attractiveness Index
TABLE 10: U.S. Minimally Invasive Gastroenterology Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Minimally Invasive Gastroenterology Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Minimally Invasive Gastroenterology Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Minimally Invasive Gastroenterology Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Minimally Invasive Gastroenterology Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Minimally Invasive Gastroenterology Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Minimally Invasive Gastroenterology Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Minimally Invasive Gastroenterology Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Minimally Invasive Gastroenterology Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Minimally Invasive Gastroenterology Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Minimally Invasive Gastroenterology Devices Market: PESTEL Analysis
TABLE 21: U.S. Minimally Invasive Gastroenterology Devices Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Minimally Invasive Gastroenterology Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 23: U.S. Minimally Invasive Gastroenterology Devices Market: Value Chain Analysis
TABLE 24: U.S. Minimally Invasive Gastroenterology Devices Market: Supply Chain Analysis
TABLE 25: U.S. Minimally Invasive Gastroenterology Devices Market: Digitalization, AI and Gastrointestinal Informatics Impact
TABLE 26: U.S. Minimally Invasive Gastroenterology Devices Market: Application & Innovation Landscape
TABLE 27: U.S. Minimally Invasive Gastroenterology Devices Market: FDA Regulatory Framework Analysis
TABLE 28: U.S. Minimally Invasive Gastroenterology Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 29: U.S. Minimally Invasive Gastroenterology Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 30: U.S. Minimally Invasive Gastroenterology Devices Market: Government Initiatives and Gastrointestinal Cancer Screening Programs
TABLE 31: U.S. Minimally Invasive Gastroenterology Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 32: U.S. Minimally Invasive Gastroenterology Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 33: U.S. Minimally Invasive Gastroenterology Devices Market: Product Category Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Product Category
TABLE 35: U.S. Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 36: U.S. Minimally Invasive Gastroenterology Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 37: U.S. Minimally Invasive Gastroenterology Devices Market: Gastrointestinal Endoscopes and Visualization Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Minimally Invasive Gastroenterology Devices Market: Endoscopic Therapeutic and Tissue-Management Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Minimally Invasive Gastroenterology Devices Market: ERCP and Pancreaticobiliary Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Minimally Invasive Gastroenterology Devices Market: Endoscopic Ultrasound and Tissue-Acquisition Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Minimally Invasive Gastroenterology Devices Market: Gastrointestinal Stents, Dilation and Enteral Access Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Minimally Invasive Gastroenterology Devices Market: Capsule, Single-Use and Specialized Endoluminal Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Minimally Invasive Gastroenterology Devices Market: Application Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Application
TABLE 45: U.S. Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 46: U.S. Minimally Invasive Gastroenterology Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 47: U.S. Minimally Invasive Gastroenterology Devices Market: Colorectal Cancer Screening, Polypectomy and Lower-GI Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Minimally Invasive Gastroenterology Devices Market: Upper Gastrointestinal, GERD and Barrett’s-Related Disorders Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Minimally Invasive Gastroenterology Devices Market: Pancreaticobiliary Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Minimally Invasive Gastroenterology Devices Market: Gastrointestinal Bleeding, Strictures and Luminal Complications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Minimally Invasive Gastroenterology Devices Market: Inflammatory Bowel and Small-Bowel Disease Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Minimally Invasive Gastroenterology Devices Market: Obesity and Metabolic Gastroenterology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Minimally Invasive Gastroenterology Devices Market: End User Snapshot, 2025
TABLE 54: Segment Dashboard; Definition and Scope, by End User
TABLE 55: U.S. Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 56: U.S. Minimally Invasive Gastroenterology Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 57: U.S. Minimally Invasive Gastroenterology Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Minimally Invasive Gastroenterology Devices Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Minimally Invasive Gastroenterology Devices Market: Gastroenterology Practices and Independent Endoscopy Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: U.S. Minimally Invasive Gastroenterology Devices Market: Academic Medical Centers and Advanced GI Referral Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Minimally Invasive Gastroenterology Devices Market: Other Specialty and Care Settings Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Minimally Invasive Gastroenterology Devices Market: Technology Type Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 64: U.S. Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 65: U.S. Minimally Invasive Gastroenterology Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 66: U.S. Minimally Invasive Gastroenterology Devices Market: Reusable Flexible Video Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Minimally Invasive Gastroenterology Devices Market: Image-Enhanced and AI-Assisted Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Minimally Invasive Gastroenterology Devices Market: Single-Use Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: U.S. Minimally Invasive Gastroenterology Devices Market: Advanced Therapeutic Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Minimally Invasive Gastroenterology Devices Market: EUS, Cholangioscopy and Capsule-Based Visualization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Minimally Invasive Gastroenterology Devices Market: Procurement Channel Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 73: U.S. Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 74: U.S. Minimally Invasive Gastroenterology Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 75: U.S. Minimally Invasive Gastroenterology Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Minimally Invasive Gastroenterology Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Minimally Invasive Gastroenterology Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Minimally Invasive Gastroenterology Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Minimally Invasive Gastroenterology Devices Market: Ambulatory and Physician-Group Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Minimally Invasive Gastroenterology Devices Market: Regional Snapshot, 2025
TABLE 81: Segment Dashboard; Definition and Scope, by Region
TABLE 82: U.S. Minimally Invasive Gastroenterology Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 83: U.S. Minimally Invasive Gastroenterology Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 84: West Region U.S. Minimally Invasive Gastroenterology Devices Market: Regional Overview and Trends
TABLE 85: West Region U.S. Minimally Invasive Gastroenterology Devices Market: Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
TABLE 86: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 88: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 89: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 92: California Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: California Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 94: California Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 95: California Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 96: California Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 97: Washington Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 98: Washington Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 99: Washington Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: Washington Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 101: Washington Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 102: Arizona Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 103: Arizona Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 104: Arizona Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 105: Arizona Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 106: Arizona Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 107: Colorado Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 108: Colorado Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 109: Colorado Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 110: Colorado Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 111: Colorado Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 112: Oregon Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 113: Oregon Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 114: Oregon Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 115: Oregon Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 116: Oregon Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: Utah Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 118: Utah Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 119: Utah Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 120: Utah Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 121: Utah Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: Nevada Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 123: Nevada Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: Nevada Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: Nevada Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 126: Nevada Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: New Mexico Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 128: New Mexico Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 129: New Mexico Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 130: New Mexico Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 131: New Mexico Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 132: Idaho Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 133: Idaho Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 134: Idaho Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 135: Idaho Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 136: Idaho Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 137: Montana Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 138: Montana Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 139: Montana Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 140: Montana Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 141: Montana Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 142: Wyoming Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 143: Wyoming Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 144: Wyoming Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 145: Wyoming Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 146: Wyoming Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 147: Alaska Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 148: Alaska Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 149: Alaska Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 150: Alaska Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 151: Alaska Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Hawaii Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 153: Hawaii Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 154: Hawaii Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 155: Hawaii Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 156: Hawaii Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 157: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market: Regional Overview and Trends
TABLE 158: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market: Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
TABLE 159: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 160: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 161: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 164: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 165: New York Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 166: New York Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 167: New York Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 168: New York Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 169: New York Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 170: Massachusetts Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 171: Massachusetts Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 172: Massachusetts Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 173: Massachusetts Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 174: Massachusetts Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 175: New Jersey Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 176: New Jersey Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 177: New Jersey Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 178: New Jersey Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 179: New Jersey Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 180: Pennsylvania Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 181: Pennsylvania Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 182: Pennsylvania Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 183: Pennsylvania Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 184: Pennsylvania Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 185: Connecticut Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 186: Connecticut Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 187: Connecticut Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 188: Connecticut Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 189: Connecticut Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 190: Maine Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 191: Maine Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 192: Maine Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 193: Maine Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 194: Maine Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 195: Vermont Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 196: Vermont Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 197: Vermont Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 198: Vermont Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 199: Vermont Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 200: New Hampshire Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 201: New Hampshire Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 202: New Hampshire Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 203: New Hampshire Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 204: New Hampshire Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 205: Rhode Island Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 206: Rhode Island Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 207: Rhode Island Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 208: Rhode Island Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 209: Rhode Island Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 210: Delaware Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 211: Delaware Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 212: Delaware Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 213: Delaware Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 214: Delaware Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 215: South Region U.S. Minimally Invasive Gastroenterology Devices Market: Regional Overview and Trends
TABLE 216: South Region U.S. Minimally Invasive Gastroenterology Devices Market: Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
TABLE 217: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 218: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 219: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 222: South Region U.S. Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 223: Texas Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 224: Texas Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 225: Texas Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 226: Texas Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 227: Texas Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 228: Florida Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 229: Florida Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 230: Florida Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 231: Florida Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 232: Florida Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 233: Georgia Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 234: Georgia Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 235: Georgia Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 236: Georgia Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 237: Georgia Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 238: North Carolina Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 239: North Carolina Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 240: North Carolina Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 241: North Carolina Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 242: North Carolina Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 243: Tennessee Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 244: Tennessee Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 245: Tennessee Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 246: Tennessee Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 247: Tennessee Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 248: South Carolina Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 249: South Carolina Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 250: South Carolina Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 251: South Carolina Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 252: South Carolina Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 253: Alabama Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 254: Alabama Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 255: Alabama Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 256: Alabama Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 257: Alabama Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 258: Mississippi Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 259: Mississippi Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 260: Mississippi Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 261: Mississippi Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 262: Mississippi Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 263: Louisiana Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 264: Louisiana Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 265: Louisiana Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 266: Louisiana Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 267: Louisiana Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 268: Arkansas Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 269: Arkansas Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 270: Arkansas Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 271: Arkansas Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 272: Arkansas Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 273: Kentucky Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 274: Kentucky Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 275: Kentucky Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 276: Kentucky Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 277: Kentucky Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 278: Oklahoma Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 279: Oklahoma Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 280: Oklahoma Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 281: Oklahoma Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 282: Oklahoma Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 283: Virginia Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 284: Virginia Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 285: Virginia Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 286: Virginia Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 287: Virginia Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 288: Maryland Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 289: Maryland Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 290: Maryland Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 291: Maryland Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 292: Maryland Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 293: West Virginia Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 294: West Virginia Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 295: West Virginia Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 296: West Virginia Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 297: West Virginia Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 298: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market: Regional Overview and Trends
TABLE 299: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market: Key Manufacturers, Gastroenterology Providers and Procurement Ecosystem
TABLE 300: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 301: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 302: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 305: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 306: Illinois Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 307: Illinois Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 308: Illinois Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 309: Illinois Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 310: Illinois Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 311: Ohio Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 312: Ohio Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 313: Ohio Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 314: Ohio Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 315: Ohio Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 316: Michigan Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 317: Michigan Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 318: Michigan Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 319: Michigan Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 320: Michigan Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 321: Minnesota Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 322: Minnesota Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 323: Minnesota Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 324: Minnesota Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 325: Minnesota Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 326: Indiana Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 327: Indiana Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 328: Indiana Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 329: Indiana Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 330: Indiana Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 331: Wisconsin Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 332: Wisconsin Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 333: Wisconsin Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 334: Wisconsin Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 335: Wisconsin Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 336: Missouri Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 337: Missouri Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 338: Missouri Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 339: Missouri Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 340: Missouri Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 341: Iowa Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 342: Iowa Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 343: Iowa Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 344: Iowa Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 345: Iowa Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 346: Kansas Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 347: Kansas Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 348: Kansas Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 349: Kansas Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 350: Kansas Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 351: Nebraska Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 352: Nebraska Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 353: Nebraska Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 354: Nebraska Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 355: Nebraska Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 356: North Dakota Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 357: North Dakota Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 358: North Dakota Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 359: North Dakota Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 360: North Dakota Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 361: South Dakota Minimally Invasive Gastroenterology Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 362: South Dakota Minimally Invasive Gastroenterology Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 363: South Dakota Minimally Invasive Gastroenterology Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 364: South Dakota Minimally Invasive Gastroenterology Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 365: South Dakota Minimally Invasive Gastroenterology Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 366: U.S. Minimally Invasive Gastroenterology Devices Market: Competitive Landscape Snapshot, 2025
TABLE 367: U.S. Minimally Invasive Gastroenterology Devices Market: Key Company Market Share Analysis, 2025
TABLE 368: U.S. Minimally Invasive Gastroenterology Devices Market: Company Positioning Matrix
TABLE 369: U.S. Minimally Invasive Gastroenterology Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 370: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 371: Olympus Corporation: Company Profile
TABLE 372: Boston Scientific Corporation: Company Profile
TABLE 373: Medtronic: Company Profile
TABLE 374: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 375: PENTAX Medical: Company Profile
TABLE 376: Cook Medical: Company Profile
TABLE 377: CONMED Corporation: Company Profile
TABLE 378: STERIS: Company Profile
TABLE 379: Ambu A/S: Company Profile
TABLE 380: Merit Medical Systems: Company Profile
TABLE 381: Micro-Tech Endoscopy USA: Company Profile
TABLE 382: ERBE USA: Company Profile
TABLE 383: B. Braun: Company Profile
TABLE 384: Cardinal Health: Company Profile
TABLE 385: Avanos Medical: Company Profile
TABLE 386: Taewoong Medical: Company Profile
TABLE 387: Creo Medical: Company Profile
TABLE 388: CapsoVision: Company Profile
TABLE 389: AnX Robotica: Company Profile
TABLE 390: EndoGastric Solutions: Company Profile
TABLE 391: Ovesco Endoscopy USA: Company Profile
TABLE 392: Lumendi: Company Profile
TABLE 393: Fractyl Health: Company Profile
TABLE 394: EndoQuest Robotics: Company Profile
TABLE 395: Laborie Medical Technologies: Company Profile
TABLE 396: U.S. Minimally Invasive Gastroenterology Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 397: U.S. Minimally Invasive Gastroenterology Devices Market: Disruptive Technologies Impact Matrix
TABLE 398: U.S. Minimally Invasive Gastroenterology Devices Market: Emerging Business Trends
TABLE 399: U.S. Minimally Invasive Gastroenterology Devices Market: Business Opportunities for Startups and Existing Players
TABLE 400: U.S. Minimally Invasive Gastroenterology Devices Market: Investment Prioritization Matrix
TABLE 401: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 402: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 403: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 404: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 405: U.S. Minimally Invasive Gastroenterology Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 406: U.S. Minimally Invasive Gastroenterology Devices Market: Go-to-Market Strategy Considerations
TABLE 407: U.S. Minimally Invasive Gastroenterology Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 408: U.S. Minimally Invasive Gastroenterology Devices Market: Scope Limitation
TABLE 409: U.S. Minimally Invasive Gastroenterology Devices Market: Data Use Limitation
TABLE 410: U.S. Minimally Invasive Gastroenterology Devices Market: Forecasting Limitation
TABLE 411: U.S. Minimally Invasive Gastroenterology Devices Market: Legal Disclaimer
TABLE 412: U.S. Minimally Invasive Gastroenterology Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Minimally Invasive Gastroenterology Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Minimally Invasive Gastroenterology Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Minimally Invasive Gastroenterology Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Gastrointestinal Endoscopes and Visualization Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Endoscopic Therapeutic and Tissue-Management Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: ERCP and Pancreaticobiliary Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Endoscopic Ultrasound and Tissue-Acquisition Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Gastrointestinal Stents, Dilation and Enteral Access Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Capsule, Single-Use and Specialized Endoluminal Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 24: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Colorectal Cancer Screening, Polypectomy and Lower-GI Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Upper Gastrointestinal, GERD and Barrett’s-Related Disorders Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Pancreaticobiliary Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Gastrointestinal Bleeding, Strictures and Luminal Complications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Inflammatory Bowel and Small-Bowel Disease Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Obesity and Metabolic Gastroenterology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 32: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Ambulatory Surgery Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Gastroenterology Practices and Independent Endoscopy Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Academic Medical Centers and Advanced GI Referral Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Other Specialty and Care Settings Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Reusable Flexible Video Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Image-Enhanced and AI-Assisted Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Single-Use Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Advanced Therapeutic Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: EUS, Cholangioscopy and Capsule-Based Visualization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 46: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Ambulatory and Physician-Group Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 53: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: West Region U.S. Minimally Invasive Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 55: West Region Market Share Analysis by State, 2025
FIGURE 56: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: California Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: Washington Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Arizona Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Colorado Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Oregon Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Utah Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Nevada Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: New Mexico Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Idaho Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Montana Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Wyoming Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Alaska Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Hawaii Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Northeast Region U.S. Minimally Invasive Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 71: Northeast Region Market Share Analysis by State, 2025
FIGURE 72: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New York Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Massachusetts Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New Jersey Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Pennsylvania Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Connecticut Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Maine Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Vermont Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Hampshire Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Rhode Island Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Delaware Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: South Region U.S. Minimally Invasive Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 84: South Region Market Share Analysis by State, 2025
FIGURE 85: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Texas Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Florida Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Georgia Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: North Carolina Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Tennessee Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: South Carolina Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Alabama Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Mississippi Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Louisiana Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Arkansas Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Kentucky Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Oklahoma Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Virginia Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Maryland Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: West Virginia Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Midwest Region U.S. Minimally Invasive Gastroenterology Devices Market Share and Leading Players, 2025
FIGURE 102: Midwest Region Market Share Analysis by State, 2025
FIGURE 103: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Illinois Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Ohio Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Michigan Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Minnesota Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Indiana Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Wisconsin Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Missouri Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Iowa Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Kansas Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Nebraska Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: North Dakota Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: South Dakota Minimally Invasive Gastroenterology Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 117: Company Positioning Matrix
FIGURE 118: Key Player Product Portfolio Benchmarking
FIGURE 119: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 120: Minimally Invasive Gastroenterology Device Innovation Roadmap
FIGURE 121: AI-Assisted Endoscopy Adoption Roadmap
FIGURE 122: Therapeutic EUS and Advanced Endoscopy Opportunity Map
FIGURE 123: Single-Use Endoscopy Growth Roadmap
FIGURE 124: Future Market Scenario Analysis, 2026–2035
FIGURE 125: Disruptive Technologies Impact Matrix
FIGURE 126: Emerging Business Trends Matrix
FIGURE 127: Investment Prioritization Matrix
FIGURE 128: Strategic Growth Roadmap for U.S. Minimally Invasive Gastroenterology Device Companies
FIGURE 129: Go-to-Market Strategy Framework
FIGURE 130: Product Positioning and Portfolio Expansion Framework
FIGURE 131: Report Scope and Disclaimer Framework